07.05.2020 – 11:30 Fraunhofer-Institut für Toxikologie und Experimentelle Medizin ITEMFraunhofer research consortium iCAIR® uses synergies to develop new medications against SARS-CoV-2 Hannover, Deutschland (ots/PRNewswire) - The new coronavirus SARS-CoV-2 has triggered a public health emergency of international concern. To date, there is neither a vaccine nor drugs for COVID-19 treatment available. Researchers of the international consortium iCAIR® are striving to develop novel anti-infective agents to treat or prevent clinically significant ... more